Medine.co.uk

Strepsils Dry & Sore Throat

Document: spc-doc_PL 00063-0692 change

SUMMARY OF PRODUCT CHARACTERISTICS

1    NAME OF THE MEDICINAL PRODUCT

Strepsils Blackcurrant Flavour Lozenges

Strepsils Dry & Sore Throat Blackcurrant Flavour Lozenges

2    QUALITATIVE AND QUANTITATIVE COMPOSITION

Amylmetacresol 0.6mg 2,4-Dichlorobenzyl Alcohol1.2mg

Ascorbic acid and sodium ascorbate equivalent to 100.0mg ascorbic acid

3    PHARMACEUTICAL FORM

Blackcurrent flavoured and coloured circular lozenge.

Strepsils brand icon is intagliated on both sides.

4    CLINICAL PARTICULARS

4.1    Therapeutic indications

For the symptomatic relief of mouth and throat infections.

4.2    Posology and method of administration

For oral administration.

Adults and children (over 6 years old):

One lozenge to be dissolved slowly in the mouth every 2-3 hours up to a maximum of 12 lozenges in 24 hours.

Not suitable for children under 6 years.

Elderly:

There is no need for dosage reduction in the elderly.

4.3    Contraindications

Hypersensitivity to any of the ingredients.

4.4    Special warnings and precautions for use

Keep all medicines out of the reach of children.

If symptoms persist consult your doctor

4.5    Interaction with other medicinal products and other forms of interaction

No clinically significant interactions are known.

4.6    Fertility, pregnancy and lactation

The safety of Strepsils has not been established, but it is not considered to constitute a hazard.

4.7    Effects on ability to drive and use machines

No adverse effects are known.

4.8    Undesirable effects

Occasionally hypersensitivity reactions.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

4.9    Overdose

Overdosage should not present a problem other than gastrointestinal discomfort. Treatment should be symptomatic.

5    PHARMACOLOGICAL PROPERTIES

5.1    Pharmacodynamic properties

2,4-Dichlorobenzyl alcohol and amylmetacresol have antiseptic properties.

Ascorbic acid provides a source of vitamin C, which may be beneficial during infection when vitamin C levels are believed to fall.

5.2 Pharmacokinetic properties

None stated.

5.3 Preclinical safety data

None available.

6    PHARMACEUTICAL PARTICULARS

6.1    List of excipients

Anthocyanins (E163)

Tartaric Acid Liquid Sucrose Liquid glucose

Blackcurrant Flavour (contains Glycerol, Propylene Glycol)

6.2    Incompatibilities

Not applicable.

6.3    Shelf life

36 months for lozenges packed in blister strips within a carton.

6.4    Special precautions for storage

Do not store above 25 °C.

6.5    Nature and contents of container

A blister push-through pack consisting of hard temper aluminium foil heat-sealed to a PVC/PVDC blister. The tray contains an appropriate number of lozenges to give pack sizes of 6, 8, 10, 12, 16, 20, 24, 32 and 36 lozenges in a cardboard carton.

6.6 Special precautions for disposal

Not applicable.

7    MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Healthcare (UK) Ltd

Slough

SL1 3UH

8    MARKETING AUTHORISATION NUMBER(S)

PL 00063/0692

9    DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

18/03/2014

10    DATE OF REVISION OF THE TEXT

18/03/2014